You are viewing an incomplete version of our website. Please click to reload the website as full version.

anti-Apolipoprotein C-III (APOC3) Antibodies

Apolipoprotein C-III is a very low density lipoprotein (VLDL) protein. Additionally we are shipping APOC3 Kits (56) and APOC3 Proteins (33) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
APOC3 345 P02656
APOC3 11814 P33622
APOC3 24207  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online

Top anti-APOC3 Antibodies at

Showing 10 out of 128 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Goat Biotin EIA, WB   0.5 mL Log in to see 6 to 8 Days
Human Goat Un-conjugated EIA, IHC (p) Formalin-Fixed, Paraffin Embedded Human Liver stained with APOC3 antib... Formalin-Fixed, Paraffin Embedded Human Placenta stained with APOC3 an... 50 μg Log in to see 6 to 8 Days
Human Rabbit Un-conjugated WB Western blot analysis of Apolipoprotein C3 expression in HEK293T (A), ... 200 μL Log in to see 9 Days
Human Goat Un-conjugated EIA, IHC (p), WB Human Liver: Formalin-Fixed, Paraffin-Embedded (FFPE) 50 μg Log in to see 6 to 8 Days
Human Goat Un-conjugated IHC (p), IP, ELISA, WB Human Liver (formalin-fixed, paraffin-embedded) stained with APOC3 ant... 50 μg Log in to see 8 to 10 Days
Human Goat Un-conjugated IHC (p), ELISA Human Placenta (formalin-fixed, paraffin-embedded) stained with APOC3 ... Human Liver (formalin-fixed, paraffin-embedded) stained with APOC3 ant... 50 μg Log in to see 8 to 10 Days
Human Goat Un-conjugated IHC (p), ELISA, WB Human Liver: Formalin-Fixed, Paraffin-Embedded (FFPE) 50 μg Log in to see 8 to 10 Days
Human Goat HRP ELISA, WB   1 mL Log in to see 4 to 5 Days
Human Goat Un-conjugated ELISA, WB   100 μg Log in to see 3 to 4 Days
Mouse Rabbit Un-conjugated ELISA, WB   100 μg Log in to see 8 to 10 Days

APOC3 Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality Conjugate
Human , , , ,
, ,
, , , , , ,
Mouse (Murine) , , ,

, , , , , , , , , , ,
Rat (Rattus) , , , ,
, , , , , , , , , , ,

Top referenced anti-APOC3 Antibodies

  1. Human Polyclonal APOC3 Primary Antibody for ELISA, WB - ABIN1842297 : Clavey, Lestavel-Delattre, Copin, Bard, Fruchart: Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E. in Arteriosclerosis, thrombosis, and vascular biology 1995 (PubMed)

More Antibodies against APOC3 Interaction Partners

Human Apolipoprotein C-III (APOC3) interaction partners

  1. HDL (show HSD11B1 Antibodies)-apoCIII has a significant and positive association with coronary heart disease .

  2. Low levels of APOA1 (show APOA1 Antibodies), APOC3, and APOA4 (show APOA4 Antibodies) are associated with risk of Alzheimer disease.

  3. APOA5 (show APOA5 Antibodies) -1131 T > C and APOC3 -455 T > C SNPs may play potent roles in the development and progression of coronary heart disease. (Meta-analysis)

  4. D25V apolipoprotein C-III is a new human amyloidogenic protein and the first conferring cardioprotection.

  5. the present findings reveal that High-altitude polycythemia -induced gastric mucosal lesion inspires the protection responses by up-regulating APOA4 (show APOA4 Antibodies) and APOC3, and down-regulating GIF (show GIF Antibodies).

  6. The current body of literature includes several methodologically sound studies that together provide consistent evidence for an association of cardiovascular events with blood apoC-III level in total plasma or in VLDL and LDL.

  7. 3238C>G polymorphism of ApoC3 gene appears to augment the propensity to develop T2DM, while -482C>T to negatively affect lipid metabolism in Saudi subjects.

  8. Clematichinenoside prevented dyslipidemia-induced atherosclerosis via hepatic PPARalpha (show PPARA Antibodies)/APOA1 (show APOA1 Antibodies)/APOA2 (show APOA2 Antibodies)/APOC3 metabolism.

  9. Data suggest that apolipoprotein C-III (ApoCIII) adopts an alternate helical conformation on the bilayer which could have functional implications.

  10. Lipoprotein associated phospholipase A2 activity and apolipoprotein C3 loss-of-function variants are involved in cardiovascular disease

Mouse (Murine) Apolipoprotein C-III (APOC3) interaction partners

  1. Severe hypertriglyceridaemia resulting from ApoCIII overexpression promotes restenosis and atherosclerosis

  2. Under conditions of islet insulin (show INS Antibodies) resistance, locally produced apoCIII is an important diabetogenic factor involved in impairment of beta-cell function.

  3. decreased ApoAI synthesis might be accounted for the lower plasma HDL (show HSD11B1 Antibodies) level in ApoCIII transgenic mice

  4. ApoCIII hyperactivates beta cell CaV1 (show CAV1 Antibodies) channels through SR-BI (show SCARB1 Antibodies)/beta1 integrin-dependent coactivation of PKA and Src (show SRC Antibodies).

  5. Increased plasma APOC3 concentrations predispose mice to diet-induced nonalcoholic fatty liver and hepatic insulin (show INS Antibodies) resistance.

  6. Glucose induces apoCIII transcription, which may represent a mechanism linking hyperglycemia, hypertriglyceridemia, and cardiovascular disease in type 2 diabetes.

  7. PGC-1beta (show PPARGC1B Antibodies) regulates plasma triglyceride metabolism through stimulating apolipoprotein C3 (APOC3) expression and elevating APOC3 levels in circulation

  8. The apoC-III metabolism may contribute to dyslipidemia in CKD, and this requires further investigation.

  9. ApoB (show APOB Antibodies) lipoproteins that contain apoCIII increase THP-1 (show GLI2 Antibodies) cell adhesion to ECs via PKCalpha (show PKCa Antibodies) and RhoA (show RHOA Antibodies)-mediated beta1-integrin activation.

  10. oxidized fatty acids may act through an APOA5 (show APOA5 Antibodies)/APOClll mechanism that contributes to lowering of TG levels other than PPAR (show PPARA Antibodies)* induction

Pig (Porcine) Apolipoprotein C-III (APOC3) interaction partners

  1. gene polymorphisms in APOA5 (show APOA5 Antibodies) and APOC3 are associated with meat quality traits in Kele pigs

  2. changes in apolipoprotein A-I (show APOA1 Antibodies) and apo (show C9orf3 Antibodies) C-III mRNA were reflected in their corresponding plasma levels

Cow (Bovine) Apolipoprotein C-III (APOC3) interaction partners

  1. apoC-I (show APOC1 Antibodies) and apoC-III inhibit lipolysis by displacing LPL (show LPL Antibodies) from lipid emulsion particles. We also propose a role for these apolipoproteins in the irreversible inactivation of LPL (show LPL Antibodies) by factors such as angptl4 (show ANGPTL4 Antibodies).

APOC3 Antigen Profile

Protein Summary

Apolipoprotein C-III is a very low density lipoprotein (VLDL) protein. APOC3 inhibits lipoprotein lipase and hepatic lipase\; it is thought to delay catabolism of triglyceride-rich particles. The APOA1, APOC3 and APOA4 genes are closely linked in both rat and human genomes. The A-I and A-IV genes are transcribed from the same strand, while the A-1 and C-III genes are convergently transcribed. An increase in apoC-III levels induces the development of hypertriglyceridemia.

Gene names and symbols associated with APOC3

  • apolipoprotein C-III (APOC3) antibody
  • apolipoprotein C-III (Apoc3) antibody
  • Apo-CIII antibody
  • Apoc antibody
  • ApoC-III antibody
  • APOC3 antibody
  • APOCIII antibody
  • HALP2 antibody

Protein level used designations for APOC3

apolipoprotein C-III , apo-CIII , apoC-III , apolipoprotein C3 , apolipoprotein C-3 , apolipoprotein CIII

451563 Pan troglodytes
696726 Macaca mulatta
345 Homo sapiens
11814 Mus musculus
24207 Rattus norvegicus
100135481 Cavia porcellus
406187 Sus scrofa
408009 Bos taurus
442970 Canis lupus familiaris
Selected quality suppliers for anti-APOC3 (APOC3) Antibodies
Did you look for something else?